In conversation with...
The Lancet HIV
Peter Hayward, Editor-in-Chief of The Lancet HIV, and Philippa Harris, Deputy Editor, speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
Episodes
Carol Strong and Stephane Ku on HIV and chemsexSeptember 28, 2022
Elijah Kakande and Gabriel Chamie on TB interventions for people with HIVAugust 30, 2022
Amir Mohareb on PrEP and hepatitis BJuly 26, 2022
Kenneth Ngure on PrEP in KenyaJuly 01, 2022
Marta Vasylyev and Casper Rokx on HIV care for displaced UkraniansMay 31, 2022
Angela Colbers and Hylke Waalewijn on treatment for children with HIVMay 03, 2022
Nabila El-Bassel on intimate partner violence and HIV March 01, 2022
Amy Justice on ageing with HIVFebruary 23, 2022
Bridget Mugisa on the epidemiology of HIV in the Middle East and north AfricaFebruary 01, 2022
Aaloke Mody and Izukanji Sikazwe on universal HIV treatment in ZambiaNovember 29, 2021
José Miro and Juliana Reyes on COVID-19 in people living with HIVNovember 01, 2021
Jon Shuter on smokers with HIVSeptember 27, 2021
Elizabeth Marie King on menopausal hormone therapyAugust 31, 2021
John Frater on COVID-19 vaccination and HIVAugust 03, 2021
Elias Dah on PrEP in west AfricaJune 28, 2021
Fatima Mir on the 2019 HIV outbreak in PakistanJune 01, 2021
Jessica Castilho and Claudia Cortes on HIV life expectancy in Latin America and the CaribbeanApril 26, 2021
Chloe Orkin on long-acting cabotegravirMarch 29, 2021
Sarah Calabrese on U=UMarch 01, 2021
Le Minh Giang and Todd Korthuis on opioid use disorder and HIV in VietnamFebruary 01, 2021
Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-BatherDecember 08, 2020
Mathebe Kopo and Alain Amstutz on HIV testing and the HOSENG trialOctober 28, 2020
Susannah Mayhew on integrating sexual health and HIV servicesSeptember 30, 2020
Ankur Gupta-Wright and Melanie Alufandika-Moyo on HIV drug resistance in MalawiSeptember 04, 2020
Di Gibb and Anna Turkova on dolutegravir for children with HIVAugust 04, 2020
Elijah Kakande and Gabriel Chamie on TB interventions for people with HIVAugust 30, 2022
Amir Mohareb on PrEP and hepatitis BJuly 26, 2022
Kenneth Ngure on PrEP in KenyaJuly 01, 2022
Marta Vasylyev and Casper Rokx on HIV care for displaced UkraniansMay 31, 2022
Angela Colbers and Hylke Waalewijn on treatment for children with HIVMay 03, 2022
Nabila El-Bassel on intimate partner violence and HIV March 01, 2022
Amy Justice on ageing with HIVFebruary 23, 2022
Bridget Mugisa on the epidemiology of HIV in the Middle East and north AfricaFebruary 01, 2022
Aaloke Mody and Izukanji Sikazwe on universal HIV treatment in ZambiaNovember 29, 2021
José Miro and Juliana Reyes on COVID-19 in people living with HIVNovember 01, 2021
Jon Shuter on smokers with HIVSeptember 27, 2021
Elizabeth Marie King on menopausal hormone therapyAugust 31, 2021
John Frater on COVID-19 vaccination and HIVAugust 03, 2021
Elias Dah on PrEP in west AfricaJune 28, 2021
Fatima Mir on the 2019 HIV outbreak in PakistanJune 01, 2021
Jessica Castilho and Claudia Cortes on HIV life expectancy in Latin America and the CaribbeanApril 26, 2021
Chloe Orkin on long-acting cabotegravirMarch 29, 2021
Sarah Calabrese on U=UMarch 01, 2021
Le Minh Giang and Todd Korthuis on opioid use disorder and HIV in VietnamFebruary 01, 2021
Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-BatherDecember 08, 2020
Mathebe Kopo and Alain Amstutz on HIV testing and the HOSENG trialOctober 28, 2020
Susannah Mayhew on integrating sexual health and HIV servicesSeptember 30, 2020
Ankur Gupta-Wright and Melanie Alufandika-Moyo on HIV drug resistance in MalawiSeptember 04, 2020
Di Gibb and Anna Turkova on dolutegravir for children with HIVAugust 04, 2020